0001179110-19-013138.txt : 20191226
0001179110-19-013138.hdr.sgml : 20191226
20191226090646
ACCESSION NUMBER: 0001179110-19-013138
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191220
FILED AS OF DATE: 20191226
DATE AS OF CHANGE: 20191226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guerin Mark Patrick
CENTRAL INDEX KEY: 0001607714
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 191308481
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
4
1
edgar.xml
FORM 4 -
X0306
4
2019-12-20
0
0001130598
Onconova Therapeutics, Inc.
ONTX
0001607714
Guerin Mark Patrick
C/O ONCONOVA THERAPEUTICS, INC.
375 PHEASANT RUN
NEWTOWN
PA
18940
0
1
0
0
Chief Financial Officer
Stock Option (right to purchase)
.31
2019-12-20
4
A
0
65000
0
A
2029-12-20
Common Stock
65000
65000
D
These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
/s/ Mark Guerin
2019-12-24